M. Golcuk Et Al. , "SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity," JOURNAL OF CHEMICAL INFORMATION AND MODELING , vol.62, no.10, pp.2490-2498, 2022
Golcuk, M. Et Al. 2022. SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity. JOURNAL OF CHEMICAL INFORMATION AND MODELING , vol.62, no.10 , 2490-2498.
Golcuk, M., Hacisuleyman, A., Yilmaz, S. Z., Taka, E., Yildiz, A., & Gür, M., (2022). SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity. JOURNAL OF CHEMICAL INFORMATION AND MODELING , vol.62, no.10, 2490-2498.
Golcuk, Mert Et Al. "SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity," JOURNAL OF CHEMICAL INFORMATION AND MODELING , vol.62, no.10, 2490-2498, 2022
Golcuk, Mert Et Al. "SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity." JOURNAL OF CHEMICAL INFORMATION AND MODELING , vol.62, no.10, pp.2490-2498, 2022
Golcuk, M. Et Al. (2022) . "SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity." JOURNAL OF CHEMICAL INFORMATION AND MODELING , vol.62, no.10, pp.2490-2498.
@article{article, author={Mert Golcuk Et Al. }, title={SARS-CoV-2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity}, journal={JOURNAL OF CHEMICAL INFORMATION AND MODELING}, year=2022, pages={2490-2498} }